Ardelyx
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ardelyx and other ETFs, options, and stocks.About ARDX
Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH.
ARDX Key Statistics
Stock Snapshot
Ardelyx(ARDX) stock is priced at $3.35, giving the company a market capitalization of 814.84M. It carries a P/E multiple of -14.62.
As of 2026-11-05, Ardelyx(ARDX) stock has fluctuated between $3.08 and $3.41. The current price stands at $3.35, placing the stock +8.9% above today's low and -1.8% off the high.
The Ardelyx(ARDX)'s current trading volume is 10.87M, compared to an average daily volume of 4.92M.
During the past year, Ardelyx(ARDX) stock moved between $2.96 at its lowest and $8.40 at its peak.
During the past year, Ardelyx(ARDX) stock moved between $2.96 at its lowest and $8.40 at its peak.
ARDX News
Ardelyx (NasdaqGM: ARDX) completed enrollment ahead of schedule in its Phase 3 ACCEL trial of IBSRELA for chronic idiopathic constipation. The ACCEL study eval...
On its third quarter of 2026 earnings call, held on Nov. 3, 2026, Ardelyx (ARDX +8.09%) reported total product revenue of $125.5 million. Expanding patient adop...
has seen a sharp swing in fortunes, with the share price well below its highs even as investors focus on what its kidney treatment portfolio could mean for futu...
Analyst ratings
100%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.